StartUPDATES: New developments from healthcare startups
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
Companies developing deep brain stimulation and other neurostimulator technologies that can control and communicate signals to and from artificial body parts (i.e. limbs, eyeballs) are the latest players in the medical device sector.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
With less than 4 months for the implementation of the FDA’s third phase of the UDI system, companies with Class II devices need to ensure steps are taken to establish UDI for their products.
Health IT company RegDesk developed a network of regulatory compliance consultants across 140 countries to help life science companies navigate the path to market. Now it’s preparing to roll out a new product that would automate the process of renewing licenses for companies’ products in these countries. In a phone interview with MedCity News, the […]